Simon Raymond is a Consultant who specialised in Medical and Scientific Research and an Alumnus of Melbourne University (Rank of Number 1 in Australia and Number 33 in the World). The above stated Researcher has acted as a Reviewer for the respected Medical Journal of Australia, has received invitations internationally to review from prestigious medical journals including Journal of American Medical Association Network. He has received award in recognition of his research by Royal Australasian College of Surgeons (PSC, 2006) and invited to conferences internationally as an official Delegate and Researcher, including that in USA and China. He has worked as the Principle Researcher in the highest-powered form of medical trial—Randomised Controlled Trial (RCT). The above stated Researcher is also a Member of the Golden Key International Society for Honoured and outstanding Academics and has been cited as a Notable Global Leader. Dr Simon Raymond's research has been indexed by well respected universities including Cornell University.

The Application of Quantum Physics to Medicine and Surgery, Site Attachment Inhibition

Lijun Wang is the chairman of Dept. of Critical care Medicine of the Affiliated Hospital of Southern Medical University, China. He has his expertise in the field of critical care medicine, especially in the management of critical maternal near-miss. He has construct a network including consultation and transfer of critical patients between tertiary referral center and Grade-II hospitals.

Coagulation, immune and inflammation, Acute kidney injury and blood purification, Acute pulmonary injury, Sepsis and Anti-sepsis

Guochang Hu is an Associate Professor of Departments of Anesthesiology and Pharmacology at the University of Illinois at Chicago. Over the past 15 years, his research has focused on acute lung injury, innate immunity and inflammation, and vascular endothelial permeability. He has established a record of successful and productive research in the areas highly relevant to lung inflammatory injury. He is currently serving as a scientific reviewer of more than 40 journals. Dr. Hu has also served as a grant reviewer for the National Institutes of Health and American Heart Association. He has received numerous teaching and research awards including a Young Investigator Award from the American Heart Association.

Innate immunity, Inflammation, Vascular endothelial permeability

Dr. Carmona is a physician-scientist focused on understanding the role of chronic inflammation triggered by infectious antigens in the development of interstitial lung diseases (ILD). Her research to date has focused on understanding the immunomodulatory effects of fungal beta-glucans (BG) in innate immune cells. Particularly; she had characterized the role of BG on dendritic cells and their participation in T-cell polarization (Th1 and Th17). Currently, her group is interested in determining the mechanisms by which BG and other infectious antigens modulate B-lymphocyte activation and how activated B-lymphocytes may drive the development of inflammation and fibrosis in a subset of patients with ILD. Her group has recently shown that BG activated B-lymphocytes release a pro-inflammatory cytokine profile that participates in neutrophil recruitment potentially contributing to lung epithelial damage. They have also identified the NLRP3 inflammasome of circulating human B-lymphocytes as a key component in innate and adaptive immune response in response to fungal and bacterial antigens. More recently, they are investigating the role of antifibrotic drugs in B-cells activation.

Immunology, B-cells biology and interstitial lung diseases.